Surgical Resection (Partial Hepatectomy)
Treatment for Hepatoblastoma
Effectiveness
90%
Safety Score
55%
Clinical Trials
500
Participants
25K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
55
DangerousModerateSafe
Treatment Details
Time to Effect
immediate
Treatment Duration
Acute event, weeks to months recovery
Evidence Quality
HIGHConfidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$15,000
Side Effect Mgmt:$5,000
Total Annual:$120,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
20
Outcome-Based Costs
Cost per Responder
$141,764.7
Cost per Remission
$150,625
Surgical Resection (Partial Hepatectomy) Outcomes
for Hepatoblastoma
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+85%
Remission Rate
+80%
Common Side Effects
Post-operative pain
+100%
Infection
+10%
Bleeding (requiring transfusion)
+8%
Bile leak
+7%
Liver insufficiency
+3%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov